Get started
Author

Judith Shanika Pelpola

Observed names: Judith S. Pelpola, Shanika Pelpola
OpenAlex ID: A5042167676
Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
2019 · Reena P. Thomas, Seema Nagpal, et al. · Clinical Cancer Research · 105
NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein–Barr Virus
2016 · Olivia Hatton, Dara Marie Strauss-Albee, et al. · Frontiers in Immunology · 54
PDF
Disparities During Family-Centered Rounds for Families Using Languages Other Than English
2025 · Judith S. Pelpola, Christina R. Rojas, et al. · PEDIATRICS · 6
CXCR4 blockade at the end of irradiation to improve local control of glioblastoma (GBM).
2018 · Reena Parada Thomas, Seema Nagpal, et al. · Journal of Clinical Oncology · 6
Association of SDF1 inhibition with local control and relative cerebral blood volume of glioblastoma.
2017 · Reena Parada Thomas, Seema Nagpal, et al. · Journal of Clinical Oncology · 3
Correction: Macrophage Exclusion after Radiation Therapy (MERT): A First-in-Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
2023 · Reena P. Thomas, Seema Nagpal, et al. · Clinical Cancer Research · 1
PDF
Disparities in the Care of Febrile Infants: Embedding Equity in Every Step of Quality Improvement
2025 · Judith S. Pelpola, Ndidi Unaka · Hospital Pediatrics
Supplementary Data from Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
2023 · Reena P. Thomas, Seema Nagpal, et al.
Supplementary Data from Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
2023 · Reena P. Thomas, Seema Nagpal, et al.
Data from Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
2023 · Reena P. Thomas, Seema Nagpal, et al.
Data from Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
2023 · Reena P. Thomas, Seema Nagpal, et al.
Works count: 11
Citation count: 175
H-index: 4
I10-index: 2
Year
Topic
Type